Pterostilbene in Berries May Enhance Muscle Fat Metabolism
Excess fat accumulation within skeletal muscle has emerged as a critical concern for metabolic health, influenced by factors such as high-fat diets, aging, and physical inactivity. Unlike subcutaneous fat, lipid droplets that accumulate in muscle cells can disrupt normal muscle function and hinder the body's ability to utilize glucose and fatty acids effectively. This impaired metabolic flexibility can lead to insulin resistance, making it essential to find ways to limit excess fat in skeletal muscle to support healthy aging and mitigate lifestyle-related diseases.
A key player in this process is the peroxisome proliferator-activated receptor δ (PPARδ), which, when activated, promotes fatty acid oxidation and helps prevent lipid accumulation within cells. Researchers have increasingly focused on food-derived bioactive compounds that might influence PPARδ signaling, although the precise effects of these substances have been unclear until now.
A team of researchers in Japan, led by Associate Professor Takakazu Mitani from Shinshu University, has identified pterostilbene as a natural dietary compound that stabilizes PPARδ and positively influences fat metabolism in muscle cells. Pterostilbene, a polyphenol found in blueberries, grapes, and other berries, has previously been associated with beneficial metabolic effects in liver and adipose tissue, but its impact on skeletal muscle was less understood. Their findings were published in the Food Bioscience journal on September 1, 2026.
Dr. Mitani noted the lack of approved treatments specifically targeting myosteatosis, which prompted their team to screen food-derived compounds for potential dietary interventions. In their screening, pterostilbene emerged as the most effective compound for reducing abnormal fat accumulation in cultured C2C12 mouse skeletal muscle cells while allowing normal muscle development to continue.
The researchers discovered that pterostilbene did not prevent fatty acids from entering muscle cells; rather, it increased the release of glycerol from the cells, indicating that stored fat was being broken down. Additionally, the treated cells exhibited higher expression of genes involved in fatty acid oxidation, suggesting that pterostilbene encourages muscle cells to utilize stored lipids for energy.
Delving deeper into the molecular mechanisms, the researchers found that pterostilbene significantly enhanced PPARδ signaling. Interestingly, instead of activating PPARδ directly, pterostilbene appeared to stabilize the protein by preventing its breakdown via the ubiquitin-proteasome pathway. This stabilization increased the availability of PPARδ within the cells, enhancing its transcriptional activity and promoting lipid metabolism.
Dr. Mitani emphasized that their findings establish a foundation for developing functional foods and nutritional supplements aimed at muscle fat metabolism. While pterostilbene shows promise, the research also sets the stage for identifying other natural compounds that could stabilize PPARδ.
As metabolic diseases become more prevalent globally, these findings may pave the way for dietary strategies that could help address obesity, type 2 diabetes, and age-related metabolic decline. However, it is important to note that the current results are based on molecular experiments in cultured mouse muscle cells and do not yet demonstrate the efficacy of pterostilbene in preventing or treating these conditions in living organisms. Further in vivo research is necessary to determine whether these effects can be replicated outside of cultured cells and to assess the safety and effectiveness of pterostilbene as a nutritional or pharmaceutical option.




